Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lauren Taiclet"'
Autor:
Emily Hotez, Maya Ayoub, Julianna Rava, Zina Jawadi, Kashia A. Rosenau, Lauren Taiclet, Leane Nasrallah, Charlotte Poplawski, Alice A. Kuo
Publikováno v:
International Journal of Medical Students, Vol 10, Iss 2 (2022)
Background: Globally, Neurodivergent, Disability, and Chronic Illness (NDCI) populations face significant health disparities. Lack of physician knowledge about NDCI is a key mechanism underlying these disparities. The current study aimed to describe
Externí odkaz:
https://doaj.org/article/f8c906b2c30e4dea9b5150139d776ba3
Autor:
Ally Peabody Smith, Lauren Taiclet, Hamasa Ebadi, Lilyana Levy, Megan Weber, Eugene M. Caruso, Nader Pouratian, Ashley Feinsinger
Publikováno v:
AJOB Empirical Bioethics. 14:111-124
Autor:
Shing Mirn Lee, Edwin Choy, Parag Patwardhan, Matthew Ingham, Lauren Taiclet, Shahnaz Singh-Kandah, Isan Chen, Gary K. Schwartz
Publikováno v:
Journal of Clinical Oncology. 35:TPS11082-TPS11082
TPS11082 Background: Well-differentiated/dedifferentiated liposarcoma (WD/DD LPS) is a sarcoma subtype of adipocytic origin characterized by amplification of cyclin dependent kinase 4 (CDK4) and MDM2. WD/DD LPS is resistant to chemotherapy and succes
Autor:
Shing Mirn Lee, Sarah DeNoble, Grazia Ambrosini, Amanda Carter, Kimberly M. Komatsubara, Shahnaz Singh-Kandah, Alexander N. Shoushtari, Suzanne Cain, Parisa Momtaz, Lauren Taiclet, Richard D. Carvajal, Tiffany Negri, Gary K. Schwartz, Danielle Lacey, Sapna Pradyuman Patel
Publikováno v:
Journal of Clinical Oncology. 35:TPS9597-TPS9597
TPS9597 Background: Uveal melanoma (UM) is a rare subtype of melanoma with no effective therapy for advanced disease. UM is characterized by mutations in GNAQ and GNA11 leading to constitutive activation of the mitogen activated protein kinase (MAPK)